Evidence map›Paper›PMID 31327085›Full record

Trial reportClinical rheumatology2019

Shared decision-making aid for juvenile idiopathic arthritis: moving from informative patient education to interactive critical thinking.

Yasser El Miedany, M El Gaafary, H Lotfy, N El Aroussy, D Mekkawy, S I Nasef, Y Farag, S Almedany, Ghada Wassif, PRINTO Egypt

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Clinical rheumatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Pooled it
  4. Pilot trial of iBDecide: Evaluating an online tool to facilitate shared decision making for adolescents and young adults with ulcerative colitis.Health expectations : an international journal of public participation in health care and health policy · 2022
    Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Treat-to-Target in Pediatric Rheumatic Diseases.Current rheumatology reports · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Yasser El MiedanyRheumatology and Rehabilitation, School of Medicine Ain Shams University, Cairo, Egypt. drelmiedany@rheumatology4u.com.ORCID http://orcid.org/0000-0002-4543-692X
M El GaafaryCommunity and Public Health, School of Medicine Ain Shams University, Cairo, Egypt.
H LotfyPediatrics, School of Medicine Cairo University, Cairo, Egypt.
N El AroussyRheumatology and Rehabilitation, School of Medicine Ain Shams University, Cairo, Egypt.
D MekkawyRheumatology and Rehabilitation, School of Medicine Ain Shams University, Cairo, Egypt.
S I NasefRheumatology and Rehabilitation, School of Medicine Suez Canal University, Ismailia, Egypt.
Y FaragPediatrics, School of Medicine Cairo University, Cairo, Egypt.
S AlmedanyRheumatology and Rehabilitation, School of Medicine Tanta University, Tanta, Egypt.
Ghada WassifAnatomy, Taibah University, Taibah, Saudi Arabia.
PRINTO Egypt
Ain Shams University · EGCairo University · EGSuez Canal University · EGTaibah University · SATanta University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo develop and evaluate an illustrated, stand-alone, interactive evidence-based shared decision making (SDM) aid for JIA children; its ability to produce positive perceived involvement of JIA patients in their own management and its impact on their adherence to therapy, school absenteeism and treatment outcomes.

methodsThe SDM aid was developed to offer information about the disease, risks and benefits of treatment. A multidisciplinary team defined SDM criteria based on international standards (IPDAS). Eight categories emerged as highly important for SDM. Each category was supported by simple illustrations in an interactive style. At the end of each category, the child is asked to make a decision in view of the information given. Ninety-four JIA children were provided with the tool, in a randomised controlled study, in comparison to a control group of 95 JIA patients treated according to standard protocols.

resultsA total of 97.5% of the study children reported comprehensibility of more than 90%. The patients' adherence to therapy was significantly (p < 0.01) higher in the SDM group, whereas stopping DMARDs for intolerability was significantly higher in the control group at 12 months of treatment. There was a significant improvement in the patient-reported outcomes in the SDM group, and absence from school was significantly higher in the control group (p < 0.01).

conclusionsThe developed SDM aid offered the children evidence-based information about the pros and cons of treatment options and improved their understanding of the disease and their ability to make an informed decision that is reflected on their adherence to therapy and better treatment outcomes. Key Points • This work represents the second generation of shared decision-making tools. • The developed tool adopts an interactive style and enhances critical thinking, giving the patients the facility of making their own decision regarding their management. • The work gives an example of core domain set of outcomes which can be used for shared decision-making interventions.

Indexed as

Arthritis, JuvenileDecision Making, SharedAdolescentChildDrug MonitoringFemaleHumansMalePatient Education as TopicPatient Reported Outcome MeasuresAdherenceArthritisInteractive thinkingJIAShared decision making

Identifiers

PMID31327085
OpenAlexW2963326030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.